OPCH · NASDAQ · STOCK
Option Care Health (OPCH) Stock Analysis
$23.37
52W $18.01 – $36.80
65/100
$3.59B
18.0
0.61
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is OPCH Bullish or Bearish?
Bullish.
Innellis AI committee rates Option Care Health (OPCH) Buy with a composite score of 65/100
, based on 6 analysts with 67% agreement.
Last updated August 17, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +9.93 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -10.07 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull & Bear Case
Bull Case
- ROE of 15.8% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- News sentiment is positive (+0.50 across 10 articles, 14d) — News
Bear Case
- Bollinger bandwidth of 19.5% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 17, 2026
Overall Committee Score
65/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 15%
of 192 Healthcare peers
Value Analyst
bullish
63
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 15.8% shows genuine earnings power backing the valuation
Growth Analyst
bullish
62
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
52
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
− Bollinger bandwidth of 19.5% signals elevated volatility
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
74
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.50 across 10 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2963.04)
Investment Thesis Evolution
Committee score moved marginally from 64.8 to 65.1.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +1 bearish signal(s).
Comparing 2026-08-16 to 2026-08-17 (1 day apart).
Technical Analysis
RSI (14)
59.5
Neutral
MACD Histogram
0.064
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$23.01
Resistance
$24.27
Bollinger %B
0.71
Inside Bands
Price vs Moving Averages
EMA 9
$23.79
Below
EMA 21
$23.18
Above
EMA 50
$22.78
Above
EMA 200
$25.88
Below
Fundamental Analysis
Valuation
55
Growth
68
Profitability
39
Financial Health
65
Cash Flow
70
Valuation
P/E Ratio
18.0×
P/B Ratio
2.94×
PEG Ratio
3.81
Dividend Yield
0.00%
52W High
$36.80
52W Low
$18.01
Quality & Growth
ROE
1565.0%
ROA
600.7%
Gross Margin
1817.2%
Operating Margin
594.2%
Revenue Growth YoY
—
Debt / Equity
1.01
AI Fundamental Assessment
P/E ratio of 18.0 (inexpensive relative to a 15-40x range); Price-to-book of 2.9x; PEG ratio of 3.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 15.7%; Return on assets of 6.0%; Net margin of 3.7%; Gross margin of 18.2%; Current ratio of 1.47 (tight short-term liquidity); Debt-to-equity of 1.01; Free cash flow per share is positive (2.24); Most recent quarter beat estimates by 3.2%; 2 consecutive earnings beats; EPS growth accelerating (-13.0% -> +12.5% QoQ); Average YoY EPS growth of 9.8%; Analyst estimates falling over recent quarters
Get the Full OPCH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →